Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2015

Jun 23, 2015

30681_dirs_2015-06-22_a7e75d1c-f95f-422d-99e2-969fd32c44c4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2015-06-18

Reporting Person: Swisher Daniel N JR (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-06-18 Stock option $6.55 A 70000 Disposed 2025-06-18 Common stock (70000) Direct

Footnotes

F1: Exercisable with respect to 25 percent of the total shares on June 18, 2016 and the remainder will vest ratably on each monthly anniversary thereafter such that the award will be fully vested on June 18, 2019.